Table 3.
Cancer | Regulation | Tissue | Cell Lines | Functions | Target Gene | Source |
---|---|---|---|---|---|---|
NSCLC | Up | n = 52 | × | Non-invasive diagnostic and prognostic marker of radioresistant NSCLC | × | [70] |
NSCLC | Up | n = 57 | A549, H460 | Promote migration and invasion | GPC3 | [71] |
NSCLC | Up | n = 5 | H358, H23 | Induce cisplatin chemoresistance | SAMD9 | [72] |
CRC | Up | n = 60 | SW480, SW620, HCT-8 | Promote proliferation and inhibit apoptosis | AMPKα2/FTO/m6A/MYC | [73] |
CRC | × | × | HCT-116 | Promote invasion | RECK | [74] |
PCa | Up | × | PC-3 | Promote migration | FOXO1, FOXO3a | [79] |
PCa | Up | n = 13 | PcaP, PC3 | Promote proliferation | FOXO1 | [75] |
PCa | Up | × | DU145, LNCaP | Inhibit proliferation | LncRNA FGF14-AS2, AJAP1 | [82] |
GC | Up | n = 70 | MKN45, SGC7901 | Promote proliferation | FOXO3 | [76] |
GC | Up | × | SGC7901 | Promote proliferation, migration, and invasion | FOXO1 | [77] |
brest cancer | Up | n = 44 | MCF-7, MDA-MB-231 | Promote migration | MTSS1 | [80] |
HCC | Up | n = 60 | HepG2 | Inhibit proliferation, migration, and invasion | FOXO1, AKT/GSK-3β/β-catenin | [78] |
bladder cancer | × | × | HT1376 | Regulate migration and invasion | TGF-β1, FOXO1 | [81] |
OC | Up | n = 62 | Caov-3, OVCAR3 | Promote migration | LncRNA HOXC-AS3 | [83] |
×: No relevant data or assays using pathological tissue or cell lines.